The European court rules on the paroxetine pay-for-delay dispute

The long-running dispute over agreements to settle patent litigation between innovator company GSK and a series of generic producers has now reached the CJEU.

Mills & Reeve life sciences lead, James Fry, considers what this ruling might mean for your patent strategy here.

Posted by


Mills & Reeve Sites navigation
A tabbed collection of Mills & Reeve sites.
My Mills & Reeve navigation
Subscribe to, or manage your My Mills & Reeve account.
My M&R


Register for My M&R to stay up-to-date with legal news and events, create brochures and bookmark pages.

Existing clients

Log in to your client extranet for free matter information, know-how and documents.


Mills & Reeve system for employees.